At FORAVISET, we have established a robust intellectual property portfolio to protect our innovative therapies and enhance our patent strategy, all aimed at fostering groundbreaking solutions in women's health innovation. Our commitment to safeguarding these advancements ensures long-term value and a competitive edge in the field.
FORAVISET holds a granted patent for the treatment of uterine hypercontractility disorders, which plays a pivotal role in our intellectual property portfolio. This patent signifies a crucial milestone in our patent strategy, allowing us to protect our innovative approach while addressing critical unmet needs in conditions such as dysmenorrhea and abnormal uterine bleeding. This foundational patent emphasizes our commitment to pioneering women's health innovation through non-hormonal therapies for uterine health.
In addition to our granted patent, our intellectual property portfolio includes a Patent Cooperation Treaty (PCT) application for the treatment of endometriosis. This application recently underwent examination, resulting in an International Search Report that found all claims to be both novel and inventive. This positive evaluation strengthens our patent strategy and provides strong assurance of the application’s validity and broad approval potential as we prepare to enter the national phase in 2026. The findings of the International Search Report further cement our confidence in Raviset® as a key innovation in women's health.
As we continue to advance Raviset® and explore new indications, we are actively planning to expand our intellectual property portfolio. This effort is part of our robust patent strategy, which includes filing additional patent applications for novel formulations, optimized delivery systems, and expanded therapeutic uses for various conditions. By broadening our patent coverage, we aim to reinforce our leadership in women's health innovation and ensure sustained progress in advancing non-hormonal therapies.
FORAVISET’s robust intellectual property portfolio, strengthened by our granted patent and the encouraging outcomes of our PCT application, positions us for sustained growth and innovation. This comprehensive patent strategy safeguards our groundbreaking work as we aim to enhance the lives of millions of women through safe, effective, and life-changing therapies in women's health innovation.
Foraviset